Elon Musk’s Neuralink gets US FDA approval for human clinical study of brain implants
Elon Musk’s brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration (FDA) to launch a first-in-human clinical study. Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. But the company’s application was rejected […]
The post Elon Musk’s Neuralink gets US FDA approval for human clinical study of brain implants appeared first on Inquirer Technology.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.